Intelsius joins BioCore to expand operations in South Korea
The collaboration aims to expand the footprint of Intelsius and its core strategy of offering products globally with local supply. Intelsius CEO David Walsh said the company’s partnership
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.